why choose us

Clinical Trials Search

Showing 9,120 of 132,656 result(s)
Cognitive-Behavioral Therapy for Opioid Use Disorder: A Manualized Pilot Study

Status: Completed

Condition: Opioid Use Disorder

Interventions: The manualized intervention, Cognitive Behavioral Therapy for Opioid Use Disorder, was co-written and developed by the study PI, Dr. Lent (see Appendi

Date: 2023-08-17

Oxygen Therapy in Children and Adolescents With Down Syndrome and Obstructive Sleep Apnea

Status: NOT_YET_RECRUITING

Condition: Down Syndrome

Interventions: Active nocturnal oxygen concentrator

Date: 2023-08-17

LLLT to Reduce Low Back Pain

Status: NOT_YET_RECRUITING

Condition: Low Back Pain

Interventions: Low-level laser therapy

Date: 2023-08-17

COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease

Status: Completed

Condition: Sickle Cell Disease

Interventions: SCD-specific COVID-19 vaccination information (SCVI) video developed by health care providers with input from a community advisory board of people wit

Date: 2023-08-17

Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery

Status: Completed

Condition: Post-Operative Complications in Cardiac Surgery

Interventions: Intravenous administration

Date: 2023-08-17

Cabozantinib in Combination With Atezolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

Status: NOT_YET_RECRUITING

Condition: Locally Advanced Adrenal Cortex Carcinoma

Interventions: Given IV

Date: 2023-08-17

Electronic Medical Record-Based Nudge to Reduce SLNB

Status: COMPLETED

Condition: Breast Cancer

Interventions: The nudge is a column in EPIC that flags patients coming to the clinic as a new visit with documented ER+ breast cancer.
The nudge flag can pop u

Date: 2023-08-17

MK-0616 (Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

Status: Completed

Condition: Arteriosclerosis

Interventions: MK-0616 20 mg tablet taken by mouth.

Date: 2023-08-17

OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+;HER2- Advanced Breast Cancer

Status: Completed

Condition: Breast Cancer

Interventions: Patients will be treated with OP-1250 once daily on a 4 week (28 day) cycle

Date: 2023-08-17

Tele-video to Improve Daily Activity

Status: Completed

Condition: Physical Inactivity

Interventions: Participants will be asked to meet individually with an Occupational Therapist (OT) via Zoom to assess activity performance, establish short-term acti

Date: 2023-08-17